Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.7%. By the end of trading, Boston Scientific fell $0.14 (-1.3%) to $10.83 on average volume. Throughout the day, 20,059,217 shares of Boston Scientific exchanged hands as compared to its average daily volume of 18,759,300 shares. The stock ranged in price between $10.81-$11.02 after having opened the day at $11.00 as compared to the previous trading day's close of $10.97. Other companies within the Health Services industry that declined today were: Orthofix International N.V ( OFIX), down 16.3%, Luminex Corporation ( LMNX), down 12.5%, Health Management Associates ( HMA), down 10.9% and Organovo Holdings ( ONVO), down 9.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $14.8 billion and is part of the health care sector. Shares are up 91.3% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet.

On the positive front, Stereotaxis ( STXS), up 228.7%, Spherix ( SPEX), up 18.5%, LCA-Vision ( LCAV), up 16.3% and American Shared Hospital Services ( AMS), up 14.1% , were all gainers within the health services industry with CareFusion ( CFN) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing